You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa

Article info

Article menu

Download PDFPDF

XML
Research
Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa

Authors

  • Peter Winskill Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Patrick GT Walker Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Jamie T Griffin Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK School of Mathematical Sciences, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Azra C Ghani Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Peter Winskill; p.winskill{at}imperial.ac.uk
View Full Text

Citation

Winskill P, Walker PG, Griffin JT, et al
Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa
BMJ Global Health 2017;2:e000090.

Publication history

  • Received May 18, 2016
  • Revised August 21, 2016
  • Accepted August 24, 2016
  • First published January 24, 2017.
Online issue publication 
May 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/